Our previous study also suggested that exosomal lncRNAs TBILA and AGAP2-AS1 exhibited powerful diagnostic efficiencies in NSCLC patients with different tumor pathologic subtypes and early stages (29). The gene discussed is TBILA; the disease is non-small cell lung carcinoma.